Influence of Biotechnological Processes, Speed of Formulation Flow and Cellular Concurrent Stream-Integration on Insulin Production from β-cells as a Result of Co-Encapsulation with a Highly Lipophilic Bile Acid-Reference-Cited by-同舟云学术

Influence of Biotechnological Processes, Speed of Formulation Flow and Cellular Concurrent Stream-Integration on Insulin Production from β-cells as a Result of Co-Encapsulation with a Highly Lipophilic Bile Acid

Published:2017-10-03 Issue:1 Volume:11 Page:65-75
ISSN:1865-5025
Container-title:Cellular and Molecular Bioengineering
language:en
Short-container-title:Cel. Mol. Bioeng.

Author:

Mooranian Armin,Negrulj Rebecca,Takechi Ryu,Jamieson Emma,Morahan Grant,Al-Salami Hani^ORCID

Funder

National Health and Medical Research Council

Alzheimer's Australia Dementia Research Foundation

Department of Health, Government of Western Australia

Diabetes Research Western Australia

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,Modeling and Simulation

Link

http://link.springer.com/article/10.1007/s12195-017-0510-y/fulltext.html

Reference65 articles.

1. Al-Salami, H., G. Butt, J. P. Fawcett, I. G. Tucker, S. Golocorbin-Kon, and M. Mikov. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. Eur. J. Drug Metab. Pharmacokinet. 33(2):101–106, 2008.

2. Al-Salami, H., G. Butt, I. Tucker, S. Golocorbin-Kon, and M. Mikov. Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats. Eur. J. Drug Metab. Pharmacokinet. 37(2):99–108, 2012.

3. Al-Salami, H., G. Butt, I. Tucker, and M. Mikov. Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics. Methods Find. Exp. Clin. Pharmacol. 30(2):107–113, 2008.

4. Al-Salami, H., G. Butt, I. Tucker, and M. Mikov. Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats. Methods Find. Exp. Clin. Pharmacol. 30(2):107–113, 2008.

5. Al-Salami, H., G. Butt, I. Tucker, R. Skrbic, S. Golocorbin-Kon, and M. Mikov. Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats. Arch. Drug Inf. 1(1):35–41, 2008.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose nano-gel incorporated with bile acids enhanced pharmacology of surgical implants;Therapeutic Delivery;2023-01

2. Applications of bile acids as biomaterials-based modulators, in biomedical science and microfluidics;Therapeutic Delivery;2022-12

3. Reduced Cytokine Tumour Necrosis Factor by Pharmacological Intervention in a Preclinical Study;Biomolecules;2022-06-23

4. Taurine Grafted Micro-Implants Improved Functions without Direct Dependency between Interleukin-6 and the Bile Acid Lithocholic Acid in Plasma;Biomedicines;2022-01-06

5. Single-Cellular Biological Effects of Cholesterol-Catabolic Bile Acid-Based Nano/Micro Capsules as Anti-Inflammatory Cell Protective Systems;Biomolecules;2022-01-04